Global Artificial Respirator

Artificial Respirator Comprehensive Study by Type (Constant Pressure Type, Constant Volume Type), Application (Hospitals & Clinics, Research Institutes, Ambulatory Surgical Centers, Other), Distribution Channel (Online, Offline), Materials (Silicon, PVC, Rubber), End- User (Adult, Pediatric) Players and Region - Global Market Outlook to 2028

Artificial Respirator Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Artificial Respirator Market Scope?
Artificial respiration is means of aiding or stimulating respiration, a metabolic process concerning the exchange of gases within the body by pulmonary ventilation, external respiration, and internal respiration. It should take the form of manually providing air for an individual who isn't breathing or isn't creating decent metabolism effort, or it should be mechanical ventilation involving the utilization of a mechanical ventilator to move air in and out of the lungs once a person is unable to breathe on their own, this machine is termed ventilator; for instance, throughout surgery with general anesthesia or once a person is during a coma or trauma. Such ways, whenever connected speedily and fitly, will avert some deaths from strangulation, drowning, choking, carbon monoxide poisoning, suffocation, and electrical shock. Revival by prompting fake breath contains primarily of 2 activities: setting up and keeping up an outside entry from the higher tract (throat, pharynx, and mouth) to the lungs and other is trading air and trading in terminal air sacs of the lungs while the heart is as yet working.

Influencing Trend:
Increasing Adoption by The Geriatrics and The Children

Market Growth Drivers:
Changes in Climate, Increasing Pollution in The Developed Countries and The Outbreak of The Infectious Diseases Affecting the Respiratory System

Challenges:
Presence of Competitors and Unfavorable Reimbursement Scenario

Restraints:
Stringent Rules for Product Approval

Opportunities:
Rapid Launch of New Technologies, Increasing Research by The Key Players and Growing Demand for Home Care Therapeutic Devices

The Artificial Respirator market study is being classified by Type (Constant Pressure Type and Constant Volume Type), by Application and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analysts at AMA predicts that Players from European will contribute to the maximum growth of Global Artificial Respirator market throughout the predicted period.

CareFusion (United States), Air Liquide Healthcare (France), Fisher & Paykel Healthcare (New Zealand), HOFFRICHTER GmbH (Germany), Drager (Germany), Phillips (Netherlands), ResMed (United States), Ambu (Denmark), Acutronic Medical Systems (Switzerland) and GaleMed (Taiwan) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Artificial Respirator market by Type, Application and Region.

On the basis of geography, the market of Artificial Respirator has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their Development Strategies
In April 2021, Dragerwerk AG & Co. KGaA acquired a majority stake in STIMIT AG. With the acquisition, Drager further expands its expertise in lung protective ventilation. STIMIT specializes in lung activation and non-invasive stimulation of respiratory muscles in intensive care patients.
In March 2022, Royal Philips, a global leader in health technology, announced at HIMSS22 that its latest Philips Capsule Surveillance solution has achieved 510(k) Market Authorization from the US Food and Drug Administration (FDA). the latest release of Philips Capsule Surveillance includes expanded interoperability with hospitals' existing mobile clinical communication and collaboration tools, electronic intensive care units (eICUs), and virtual care population health management systems, providing more visibility into live streaming data. do. Waveforms, device alarms, and contextual alerts.


Key Target Audience
Manufacturers of Artificial Respirator, Suppliers and Distributors of Artificial Respirator, Governmental and Regulatory bodies, End-Users and Potential Investors

Artificial Respirator Market Study: Important Years
AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Historical Period2018-2022
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Major Highlights of Market Study

Demand Determinants: Identifying top-notch application and business segments that seek high growth potentials in Artificial Respirator Market.

Key Strategic Developments: To target untapped regions more aggressively by focusing on product/service developments, innovation and R & D, new launches, Merger & acquisitions, JVs & partnerships.

Forces & Market Dynamics: Growth drivers, restraints & opportunities available in Artificial Respirator industry is examined with reference relevant market sectors and sub-sectors.

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research features not just specific market sizing estimates, but also includes significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets, To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.

Report Objectives / Segmentation Covered

By Type
  • Constant Pressure Type
  • Constant Volume Type
By Application
  • Hospitals & Clinics
  • Research Institutes
  • Ambulatory Surgical Centers
  • Other
By Distribution Channel
  • Online
  • Offline

By Materials
  • Silicon
  • PVC
  • Rubber

By End- User
  • Adult
  • Pediatric

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Changes in Climate
      • 3.2.2. Increasing Pollution in The Developed Countries
      • 3.2.3. The Outbreak of The Infectious Diseases Affecting the Respiratory System
    • 3.3. Market Challenges
      • 3.3.1. Presence of Competitors
      • 3.3.2. Unfavorable Reimbursement Scenario
    • 3.4. Market Trends
      • 3.4.1. Increasing Adoption by The Geriatrics and The Children
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Respirator, by Type, Application, Distribution Channel, Materials, End- User and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Artificial Respirator (Value)
      • 5.2.1. Global Artificial Respirator by: Type (Value)
        • 5.2.1.1. Constant Pressure Type
        • 5.2.1.2. Constant Volume Type
      • 5.2.2. Global Artificial Respirator by: Application (Value)
        • 5.2.2.1. Hospitals & Clinics
        • 5.2.2.2. Research Institutes
        • 5.2.2.3. Ambulatory Surgical Centers
        • 5.2.2.4. Other
      • 5.2.3. Global Artificial Respirator by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Artificial Respirator by: Materials (Value)
        • 5.2.4.1. Silicon
        • 5.2.4.2. PVC
        • 5.2.4.3. Rubber
      • 5.2.5. Global Artificial Respirator by: End- User (Value)
        • 5.2.5.1. Adult
        • 5.2.5.2. Pediatric
      • 5.2.6. Global Artificial Respirator Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Artificial Respirator (Price)
      • 5.3.1. Global Artificial Respirator by: Type (Price)
  • 6. Artificial Respirator: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. CareFusion (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Air Liquide Healthcare (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Fisher & Paykel Healthcare (New Zealand)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. HOFFRICHTER GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Drager (Germany)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Phillips (Netherlands)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ResMed (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Ambu (Denmark)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Acutronic Medical Systems (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. GaleMed (Taiwan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Artificial Respirator Sale, by Type, Application, Distribution Channel, Materials, End- User and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Artificial Respirator (Value)
      • 7.2.1. Global Artificial Respirator by: Type (Value)
        • 7.2.1.1. Constant Pressure Type
        • 7.2.1.2. Constant Volume Type
      • 7.2.2. Global Artificial Respirator by: Application (Value)
        • 7.2.2.1. Hospitals & Clinics
        • 7.2.2.2. Research Institutes
        • 7.2.2.3. Ambulatory Surgical Centers
        • 7.2.2.4. Other
      • 7.2.3. Global Artificial Respirator by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Artificial Respirator by: Materials (Value)
        • 7.2.4.1. Silicon
        • 7.2.4.2. PVC
        • 7.2.4.3. Rubber
      • 7.2.5. Global Artificial Respirator by: End- User (Value)
        • 7.2.5.1. Adult
        • 7.2.5.2. Pediatric
      • 7.2.6. Global Artificial Respirator Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Artificial Respirator (Price)
      • 7.3.1. Global Artificial Respirator by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Respirator: by Type(USD Million)
  • Table 2. Artificial Respirator Constant Pressure Type , by Region USD Million (2017-2022)
  • Table 3. Artificial Respirator Constant Volume Type , by Region USD Million (2017-2022)
  • Table 4. Artificial Respirator: by Application(USD Million)
  • Table 5. Artificial Respirator Hospitals & Clinics , by Region USD Million (2017-2022)
  • Table 6. Artificial Respirator Research Institutes , by Region USD Million (2017-2022)
  • Table 7. Artificial Respirator Ambulatory Surgical Centers , by Region USD Million (2017-2022)
  • Table 8. Artificial Respirator Other , by Region USD Million (2017-2022)
  • Table 9. Artificial Respirator: by Distribution Channel(USD Million)
  • Table 10. Artificial Respirator Online , by Region USD Million (2017-2022)
  • Table 11. Artificial Respirator Offline , by Region USD Million (2017-2022)
  • Table 12. Artificial Respirator: by Materials(USD Million)
  • Table 13. Artificial Respirator Silicon , by Region USD Million (2017-2022)
  • Table 14. Artificial Respirator PVC , by Region USD Million (2017-2022)
  • Table 15. Artificial Respirator Rubber , by Region USD Million (2017-2022)
  • Table 16. Artificial Respirator: by End- User(USD Million)
  • Table 17. Artificial Respirator Adult , by Region USD Million (2017-2022)
  • Table 18. Artificial Respirator Pediatric , by Region USD Million (2017-2022)
  • Table 19. South America Artificial Respirator, by Country USD Million (2017-2022)
  • Table 20. South America Artificial Respirator, by Type USD Million (2017-2022)
  • Table 21. South America Artificial Respirator, by Application USD Million (2017-2022)
  • Table 22. South America Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 23. South America Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 24. South America Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 25. Brazil Artificial Respirator, by Type USD Million (2017-2022)
  • Table 26. Brazil Artificial Respirator, by Application USD Million (2017-2022)
  • Table 27. Brazil Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 28. Brazil Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 29. Brazil Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 30. Argentina Artificial Respirator, by Type USD Million (2017-2022)
  • Table 31. Argentina Artificial Respirator, by Application USD Million (2017-2022)
  • Table 32. Argentina Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 33. Argentina Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 34. Argentina Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 35. Rest of South America Artificial Respirator, by Type USD Million (2017-2022)
  • Table 36. Rest of South America Artificial Respirator, by Application USD Million (2017-2022)
  • Table 37. Rest of South America Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 38. Rest of South America Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 39. Rest of South America Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 40. Asia Pacific Artificial Respirator, by Country USD Million (2017-2022)
  • Table 41. Asia Pacific Artificial Respirator, by Type USD Million (2017-2022)
  • Table 42. Asia Pacific Artificial Respirator, by Application USD Million (2017-2022)
  • Table 43. Asia Pacific Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 44. Asia Pacific Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 45. Asia Pacific Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 46. China Artificial Respirator, by Type USD Million (2017-2022)
  • Table 47. China Artificial Respirator, by Application USD Million (2017-2022)
  • Table 48. China Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 49. China Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 50. China Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 51. Japan Artificial Respirator, by Type USD Million (2017-2022)
  • Table 52. Japan Artificial Respirator, by Application USD Million (2017-2022)
  • Table 53. Japan Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 54. Japan Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 55. Japan Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 56. India Artificial Respirator, by Type USD Million (2017-2022)
  • Table 57. India Artificial Respirator, by Application USD Million (2017-2022)
  • Table 58. India Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 59. India Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 60. India Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 61. South Korea Artificial Respirator, by Type USD Million (2017-2022)
  • Table 62. South Korea Artificial Respirator, by Application USD Million (2017-2022)
  • Table 63. South Korea Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 64. South Korea Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 65. South Korea Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 66. Taiwan Artificial Respirator, by Type USD Million (2017-2022)
  • Table 67. Taiwan Artificial Respirator, by Application USD Million (2017-2022)
  • Table 68. Taiwan Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 69. Taiwan Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 70. Taiwan Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 71. Australia Artificial Respirator, by Type USD Million (2017-2022)
  • Table 72. Australia Artificial Respirator, by Application USD Million (2017-2022)
  • Table 73. Australia Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 74. Australia Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 75. Australia Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 76. Rest of Asia-Pacific Artificial Respirator, by Type USD Million (2017-2022)
  • Table 77. Rest of Asia-Pacific Artificial Respirator, by Application USD Million (2017-2022)
  • Table 78. Rest of Asia-Pacific Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 79. Rest of Asia-Pacific Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 80. Rest of Asia-Pacific Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 81. Europe Artificial Respirator, by Country USD Million (2017-2022)
  • Table 82. Europe Artificial Respirator, by Type USD Million (2017-2022)
  • Table 83. Europe Artificial Respirator, by Application USD Million (2017-2022)
  • Table 84. Europe Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 85. Europe Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 86. Europe Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 87. Germany Artificial Respirator, by Type USD Million (2017-2022)
  • Table 88. Germany Artificial Respirator, by Application USD Million (2017-2022)
  • Table 89. Germany Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 90. Germany Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 91. Germany Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 92. France Artificial Respirator, by Type USD Million (2017-2022)
  • Table 93. France Artificial Respirator, by Application USD Million (2017-2022)
  • Table 94. France Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 95. France Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 96. France Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 97. Italy Artificial Respirator, by Type USD Million (2017-2022)
  • Table 98. Italy Artificial Respirator, by Application USD Million (2017-2022)
  • Table 99. Italy Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 100. Italy Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 101. Italy Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 102. United Kingdom Artificial Respirator, by Type USD Million (2017-2022)
  • Table 103. United Kingdom Artificial Respirator, by Application USD Million (2017-2022)
  • Table 104. United Kingdom Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 105. United Kingdom Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 106. United Kingdom Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 107. Netherlands Artificial Respirator, by Type USD Million (2017-2022)
  • Table 108. Netherlands Artificial Respirator, by Application USD Million (2017-2022)
  • Table 109. Netherlands Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 110. Netherlands Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 111. Netherlands Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 112. Rest of Europe Artificial Respirator, by Type USD Million (2017-2022)
  • Table 113. Rest of Europe Artificial Respirator, by Application USD Million (2017-2022)
  • Table 114. Rest of Europe Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 115. Rest of Europe Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 116. Rest of Europe Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 117. MEA Artificial Respirator, by Country USD Million (2017-2022)
  • Table 118. MEA Artificial Respirator, by Type USD Million (2017-2022)
  • Table 119. MEA Artificial Respirator, by Application USD Million (2017-2022)
  • Table 120. MEA Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 121. MEA Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 122. MEA Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 123. Middle East Artificial Respirator, by Type USD Million (2017-2022)
  • Table 124. Middle East Artificial Respirator, by Application USD Million (2017-2022)
  • Table 125. Middle East Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 126. Middle East Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 127. Middle East Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 128. Africa Artificial Respirator, by Type USD Million (2017-2022)
  • Table 129. Africa Artificial Respirator, by Application USD Million (2017-2022)
  • Table 130. Africa Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 131. Africa Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 132. Africa Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 133. North America Artificial Respirator, by Country USD Million (2017-2022)
  • Table 134. North America Artificial Respirator, by Type USD Million (2017-2022)
  • Table 135. North America Artificial Respirator, by Application USD Million (2017-2022)
  • Table 136. North America Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 137. North America Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 138. North America Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 139. United States Artificial Respirator, by Type USD Million (2017-2022)
  • Table 140. United States Artificial Respirator, by Application USD Million (2017-2022)
  • Table 141. United States Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 142. United States Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 143. United States Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 144. Canada Artificial Respirator, by Type USD Million (2017-2022)
  • Table 145. Canada Artificial Respirator, by Application USD Million (2017-2022)
  • Table 146. Canada Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 147. Canada Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 148. Canada Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 149. Mexico Artificial Respirator, by Type USD Million (2017-2022)
  • Table 150. Mexico Artificial Respirator, by Application USD Million (2017-2022)
  • Table 151. Mexico Artificial Respirator, by Distribution Channel USD Million (2017-2022)
  • Table 152. Mexico Artificial Respirator, by Materials USD Million (2017-2022)
  • Table 153. Mexico Artificial Respirator, by End- User USD Million (2017-2022)
  • Table 154. Artificial Respirator: by Type(USD/Units)
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Artificial Respirator: by Type(USD Million)
  • Table 166. Artificial Respirator Constant Pressure Type , by Region USD Million (2023-2028)
  • Table 167. Artificial Respirator Constant Volume Type , by Region USD Million (2023-2028)
  • Table 168. Artificial Respirator: by Application(USD Million)
  • Table 169. Artificial Respirator Hospitals & Clinics , by Region USD Million (2023-2028)
  • Table 170. Artificial Respirator Research Institutes , by Region USD Million (2023-2028)
  • Table 171. Artificial Respirator Ambulatory Surgical Centers , by Region USD Million (2023-2028)
  • Table 172. Artificial Respirator Other , by Region USD Million (2023-2028)
  • Table 173. Artificial Respirator: by Distribution Channel(USD Million)
  • Table 174. Artificial Respirator Online , by Region USD Million (2023-2028)
  • Table 175. Artificial Respirator Offline , by Region USD Million (2023-2028)
  • Table 176. Artificial Respirator: by Materials(USD Million)
  • Table 177. Artificial Respirator Silicon , by Region USD Million (2023-2028)
  • Table 178. Artificial Respirator PVC , by Region USD Million (2023-2028)
  • Table 179. Artificial Respirator Rubber , by Region USD Million (2023-2028)
  • Table 180. Artificial Respirator: by End- User(USD Million)
  • Table 181. Artificial Respirator Adult , by Region USD Million (2023-2028)
  • Table 182. Artificial Respirator Pediatric , by Region USD Million (2023-2028)
  • Table 183. South America Artificial Respirator, by Country USD Million (2023-2028)
  • Table 184. South America Artificial Respirator, by Type USD Million (2023-2028)
  • Table 185. South America Artificial Respirator, by Application USD Million (2023-2028)
  • Table 186. South America Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 187. South America Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 188. South America Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 189. Brazil Artificial Respirator, by Type USD Million (2023-2028)
  • Table 190. Brazil Artificial Respirator, by Application USD Million (2023-2028)
  • Table 191. Brazil Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 192. Brazil Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 193. Brazil Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 194. Argentina Artificial Respirator, by Type USD Million (2023-2028)
  • Table 195. Argentina Artificial Respirator, by Application USD Million (2023-2028)
  • Table 196. Argentina Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 197. Argentina Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 198. Argentina Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 199. Rest of South America Artificial Respirator, by Type USD Million (2023-2028)
  • Table 200. Rest of South America Artificial Respirator, by Application USD Million (2023-2028)
  • Table 201. Rest of South America Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 202. Rest of South America Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 203. Rest of South America Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 204. Asia Pacific Artificial Respirator, by Country USD Million (2023-2028)
  • Table 205. Asia Pacific Artificial Respirator, by Type USD Million (2023-2028)
  • Table 206. Asia Pacific Artificial Respirator, by Application USD Million (2023-2028)
  • Table 207. Asia Pacific Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 208. Asia Pacific Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 209. Asia Pacific Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 210. China Artificial Respirator, by Type USD Million (2023-2028)
  • Table 211. China Artificial Respirator, by Application USD Million (2023-2028)
  • Table 212. China Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 213. China Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 214. China Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 215. Japan Artificial Respirator, by Type USD Million (2023-2028)
  • Table 216. Japan Artificial Respirator, by Application USD Million (2023-2028)
  • Table 217. Japan Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 218. Japan Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 219. Japan Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 220. India Artificial Respirator, by Type USD Million (2023-2028)
  • Table 221. India Artificial Respirator, by Application USD Million (2023-2028)
  • Table 222. India Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 223. India Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 224. India Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 225. South Korea Artificial Respirator, by Type USD Million (2023-2028)
  • Table 226. South Korea Artificial Respirator, by Application USD Million (2023-2028)
  • Table 227. South Korea Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 228. South Korea Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 229. South Korea Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 230. Taiwan Artificial Respirator, by Type USD Million (2023-2028)
  • Table 231. Taiwan Artificial Respirator, by Application USD Million (2023-2028)
  • Table 232. Taiwan Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 233. Taiwan Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 234. Taiwan Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 235. Australia Artificial Respirator, by Type USD Million (2023-2028)
  • Table 236. Australia Artificial Respirator, by Application USD Million (2023-2028)
  • Table 237. Australia Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 238. Australia Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 239. Australia Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 240. Rest of Asia-Pacific Artificial Respirator, by Type USD Million (2023-2028)
  • Table 241. Rest of Asia-Pacific Artificial Respirator, by Application USD Million (2023-2028)
  • Table 242. Rest of Asia-Pacific Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 243. Rest of Asia-Pacific Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 244. Rest of Asia-Pacific Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 245. Europe Artificial Respirator, by Country USD Million (2023-2028)
  • Table 246. Europe Artificial Respirator, by Type USD Million (2023-2028)
  • Table 247. Europe Artificial Respirator, by Application USD Million (2023-2028)
  • Table 248. Europe Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 249. Europe Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 250. Europe Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 251. Germany Artificial Respirator, by Type USD Million (2023-2028)
  • Table 252. Germany Artificial Respirator, by Application USD Million (2023-2028)
  • Table 253. Germany Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 254. Germany Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 255. Germany Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 256. France Artificial Respirator, by Type USD Million (2023-2028)
  • Table 257. France Artificial Respirator, by Application USD Million (2023-2028)
  • Table 258. France Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 259. France Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 260. France Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 261. Italy Artificial Respirator, by Type USD Million (2023-2028)
  • Table 262. Italy Artificial Respirator, by Application USD Million (2023-2028)
  • Table 263. Italy Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 264. Italy Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 265. Italy Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 266. United Kingdom Artificial Respirator, by Type USD Million (2023-2028)
  • Table 267. United Kingdom Artificial Respirator, by Application USD Million (2023-2028)
  • Table 268. United Kingdom Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 269. United Kingdom Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 270. United Kingdom Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 271. Netherlands Artificial Respirator, by Type USD Million (2023-2028)
  • Table 272. Netherlands Artificial Respirator, by Application USD Million (2023-2028)
  • Table 273. Netherlands Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 274. Netherlands Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 275. Netherlands Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 276. Rest of Europe Artificial Respirator, by Type USD Million (2023-2028)
  • Table 277. Rest of Europe Artificial Respirator, by Application USD Million (2023-2028)
  • Table 278. Rest of Europe Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 279. Rest of Europe Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 280. Rest of Europe Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 281. MEA Artificial Respirator, by Country USD Million (2023-2028)
  • Table 282. MEA Artificial Respirator, by Type USD Million (2023-2028)
  • Table 283. MEA Artificial Respirator, by Application USD Million (2023-2028)
  • Table 284. MEA Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 285. MEA Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 286. MEA Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 287. Middle East Artificial Respirator, by Type USD Million (2023-2028)
  • Table 288. Middle East Artificial Respirator, by Application USD Million (2023-2028)
  • Table 289. Middle East Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 290. Middle East Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 291. Middle East Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 292. Africa Artificial Respirator, by Type USD Million (2023-2028)
  • Table 293. Africa Artificial Respirator, by Application USD Million (2023-2028)
  • Table 294. Africa Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 295. Africa Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 296. Africa Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 297. North America Artificial Respirator, by Country USD Million (2023-2028)
  • Table 298. North America Artificial Respirator, by Type USD Million (2023-2028)
  • Table 299. North America Artificial Respirator, by Application USD Million (2023-2028)
  • Table 300. North America Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 301. North America Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 302. North America Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 303. United States Artificial Respirator, by Type USD Million (2023-2028)
  • Table 304. United States Artificial Respirator, by Application USD Million (2023-2028)
  • Table 305. United States Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 306. United States Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 307. United States Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 308. Canada Artificial Respirator, by Type USD Million (2023-2028)
  • Table 309. Canada Artificial Respirator, by Application USD Million (2023-2028)
  • Table 310. Canada Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 311. Canada Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 312. Canada Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 313. Mexico Artificial Respirator, by Type USD Million (2023-2028)
  • Table 314. Mexico Artificial Respirator, by Application USD Million (2023-2028)
  • Table 315. Mexico Artificial Respirator, by Distribution Channel USD Million (2023-2028)
  • Table 316. Mexico Artificial Respirator, by Materials USD Million (2023-2028)
  • Table 317. Mexico Artificial Respirator, by End- User USD Million (2023-2028)
  • Table 318. Artificial Respirator: by Type(USD/Units)
  • Table 319. Research Programs/Design for This Report
  • Table 320. Key Data Information from Secondary Sources
  • Table 321. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Respirator: by Type USD Million (2017-2022)
  • Figure 5. Global Artificial Respirator: by Application USD Million (2017-2022)
  • Figure 6. Global Artificial Respirator: by Distribution Channel USD Million (2017-2022)
  • Figure 7. Global Artificial Respirator: by Materials USD Million (2017-2022)
  • Figure 8. Global Artificial Respirator: by End- User USD Million (2017-2022)
  • Figure 9. South America Artificial Respirator Share (%), by Country
  • Figure 10. Asia Pacific Artificial Respirator Share (%), by Country
  • Figure 11. Europe Artificial Respirator Share (%), by Country
  • Figure 12. MEA Artificial Respirator Share (%), by Country
  • Figure 13. North America Artificial Respirator Share (%), by Country
  • Figure 14. Global Artificial Respirator: by Type USD/Units (2017-2022)
  • Figure 15. Global Artificial Respirator share by Players 2022 (%)
  • Figure 16. Global Artificial Respirator share by Players (Top 3) 2022(%)
  • Figure 17. Global Artificial Respirator share by Players (Top 5) 2022(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. CareFusion (United States) Revenue, Net Income and Gross profit
  • Figure 20. CareFusion (United States) Revenue: by Geography 2022
  • Figure 21. Air Liquide Healthcare (France) Revenue, Net Income and Gross profit
  • Figure 22. Air Liquide Healthcare (France) Revenue: by Geography 2022
  • Figure 23. Fisher & Paykel Healthcare (New Zealand) Revenue, Net Income and Gross profit
  • Figure 24. Fisher & Paykel Healthcare (New Zealand) Revenue: by Geography 2022
  • Figure 25. HOFFRICHTER GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 26. HOFFRICHTER GmbH (Germany) Revenue: by Geography 2022
  • Figure 27. Drager (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Drager (Germany) Revenue: by Geography 2022
  • Figure 29. Phillips (Netherlands) Revenue, Net Income and Gross profit
  • Figure 30. Phillips (Netherlands) Revenue: by Geography 2022
  • Figure 31. ResMed (United States) Revenue, Net Income and Gross profit
  • Figure 32. ResMed (United States) Revenue: by Geography 2022
  • Figure 33. Ambu (Denmark) Revenue, Net Income and Gross profit
  • Figure 34. Ambu (Denmark) Revenue: by Geography 2022
  • Figure 35. Acutronic Medical Systems (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Acutronic Medical Systems (Switzerland) Revenue: by Geography 2022
  • Figure 37. GaleMed (Taiwan) Revenue, Net Income and Gross profit
  • Figure 38. GaleMed (Taiwan) Revenue: by Geography 2022
  • Figure 39. Global Artificial Respirator: by Type USD Million (2023-2028)
  • Figure 40. Global Artificial Respirator: by Application USD Million (2023-2028)
  • Figure 41. Global Artificial Respirator: by Distribution Channel USD Million (2023-2028)
  • Figure 42. Global Artificial Respirator: by Materials USD Million (2023-2028)
  • Figure 43. Global Artificial Respirator: by End- User USD Million (2023-2028)
  • Figure 44. South America Artificial Respirator Share (%), by Country
  • Figure 45. Asia Pacific Artificial Respirator Share (%), by Country
  • Figure 46. Europe Artificial Respirator Share (%), by Country
  • Figure 47. MEA Artificial Respirator Share (%), by Country
  • Figure 48. North America Artificial Respirator Share (%), by Country
  • Figure 49. Global Artificial Respirator: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • CareFusion (United States)
  • Air Liquide Healthcare (France)
  • Fisher & Paykel Healthcare (New Zealand)
  • HOFFRICHTER GmbH (Germany)
  • Drager (Germany)
  • Phillips (Netherlands)
  • ResMed (United States)
  • Ambu (Denmark)
  • Acutronic Medical Systems (Switzerland)
  • GaleMed (Taiwan)
Select User Access Type

Key Highlights of Report


Apr 2023 243 Pages 64 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Artificial Respirator Quantitative research analysis
Global Artificial Respirator Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The prominent players of Global Artificial Respirator market are CareFusion (United States), Air Liquide Healthcare (France), Fisher & Paykel Healthcare (New Zealand), HOFFRICHTER GmbH (Germany), Drager (Germany), Phillips (Netherlands), ResMed (United States), Ambu (Denmark), Acutronic Medical Systems (Switzerland) and GaleMed (Taiwan).
In this highly competitive & fast evolving Artificial Respirator industry, the top strategic priorities would remain consistent like innovation, R&D, and M&A.
Hospitals & Clinics, Research Institutes, Ambulatory Surgical Centers and Other are the potential customers of Artificial Respirator industry.

Know More About Global Artificial Respirator Report?

Have a Query? Click Here

Other Related Reports

Portable Ultrasound Machine Comprehensive Study by Type (Hand-Carried Systems, Bedside Systems), Application (Gynecology, Radiology, Cardiology, Urology, Ophthalmology, Critical Care Medicine, Others...
$ 3450
CT Simulators Comprehensive Study by Type (Multi-Slice CT Simulators, Large Bore CT Simulators, Others), Application (Cardiology, Oncology, Neurology, Others), End Users (Hospitals, Clinics, Others) ...
$ 3500
Cell Harvesters Comprehensive Study by Application (Cell Proliferation Assays, Mixed Lymphocyte Culture (MLC) Assays, Receptor-binding Assays, Single-Stranded Template DNA Harvesting), Modality (Manu...
$ 3650
Medical Ceramics Comprehensive Study by Type (Bioinert Ceramics (Alumina and Zirconia), Bioactive Ceramics (Hydroxyapatite and Glass Ceramics), Bioresorbable Ceramics, Piezo-ceramics), Application (R...
$ 3650
Wrist Orthosis Comprehensive Study by Type (Ordinary Splint Type, Inflatable Type), Application (Children, Adults), End Users (Adults, Children), Materials Used (Thermoplastic, Canvas, Metal) Players...
$ 3500
Breathing Exercise Machine Comprehensive Study by Type (Single Flow Breathing Exercise Devices, Two Flow Breathing Exercise Devices, Three Flow Breathing Exercise Devices), Application (Hospitals, Cl...
$ 3750